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Abstract
Background: The aggregation of the baker’s yeast prion Ure2p is at the origin of the [URE3] trait. The Q- and N-rich N-
terminal part of the protein is believed to drive Ure2p assembly into fibrils of amyloid nature and the fibrillar forms of full-
length Ure2p and its N-terminal part generated in vitro have been shown to induce [URE3] occurrence when introduced into
yeast cells. This has led to the view that the fibrillar form of the N-terminal part of the protein is sufficient for the recruitment
of constitutive Ure2p and that it imprints its amyloid structure to full-length Ure2p.
Results: Herewegenerate asetofUre2pN-terminal fragments,documenttheirassemblyandstructuralpropertiesandcompare
them to that of full-length Ure2p. We identify the minimal region critical for the assembly of Ure2p N-terminal part into amyloids
and show that such fibrils are unable to seed the assembly of full length Ure2p unlike fibrils made of intact Ure2p.
Conclusion: Our results clearly indicate that fibrillar Ure2p shares no structural similarities with the amyloid fibrils made of
Ure2p N-terminal part. Our results further suggest that the induction of [URE3] by fibrils made of full-length Ure2p is likely
the consequence of fibrils growth by depletion of cytosolic Ure2p while it is the consequence of de novo formation of prion
particles following, for example, titration within the cells of a specific set of molecular chaperones when fibrils made of
Ure2p N-terminal domain are introduced within the cytoplasm.
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Introduction
Prions are infectious proteins [1]. In the baker’s yeast Saccharomyces
cerevisiae they are at the origin of the occurrence, maintenance,
transmission in a non-mendelian manner and propagation of 3 traits,
the [URE3], [PSI
+]a n d[ PIN
+] phenotypes [2–4]. As prion
emergence is neither accompanied by changes in the chemical
nature of the infectious protein nor by its cleavage/degradation, it is
widely believed that prion ‘‘infectivity’’ is the consequence of
structural rearrangement of the prions leading to sustained function
alteration and aggregation [5]. Primary structure analysis reveals that
the three prions identified so far in yeast possess domains with
unusual amino acid composition. Indeed these domains that can be
N- or C-terminal are unusually rich in Q and N and to a lesser extent
G, S and T residues [6]. While these domains arepoorly structured in
the constitutive form of prions, they are subject to conformational
rearrangements in the form of the protein associated to the prion
traits [7–9]. A number of genetic screens highlighted the importance
of these domains for prion traits occurrence and propagation.
Deletion studies have also revealed that the functional domains of the
proteins affect prion conversion and allowed delineating minimal
prion domains which overexpression, in a context where full-length
prions are expressed, induces very significantly and efficiently prion
phenotypes [10–12].
The prion domain of Ure2p is N-terminal and spans residues 1–
93 [13]. A shorter fragment spanning residues 1–65 induces
[URE3] [14]. In vitro, under physiological conditions, full-length
Ure2p assembles into helical twisted fibrils that are ,20 nm wide
[13,15] that lack amyloid signature [7,16–20] while the prion
domain in isolation assembles into ,5 nm wide amyloid fibrils
[20–21]. Comparison of the assembly kinetics of full-length Ure2p
and Ure2p 1–93 reveals that the N-terminal domain assembles
into protein fibrils faster and more readily than the full-length
protein [6]. Both fibrils induce [URE3] when reintroduced in yeast
cells [22] suggesting that both kinds of fibrils seed the assembly of
constitutively expressed Ure2p.
To further narrow the length of the prion domain to the
minimal size necessary and sufficient for assembly into fibrils we
generated a set of Ure2p N-terminal fragments and documented
their assembly properties and the structural characteristics of the
assemblies. We show that the N-terminal 42 amino acid residues of
Ure2p do not assemble into fibrils that bind thioflavin T while the
peptides 1–79 and 1–93 do. This suggests that the minimal region
critical for assembly into fibrils spans amino acid residues 43–79.
We show that this polypeptide which N content is extremely high
(57% of amino acid residues) assembles indeed into fibrils.
To determine whether the induction of [URE3] upon
reintroduction of fibrils made of Ure2p N-terminal domain is
PLoS ONE | www.plosone.org 1 March 2010 | Volume 5 | Issue 3 | e9760the consequence of Ure2p 1–93 seeded assembly of endogenous
Ure2p or due to de novo aggregation of endogenous Ure2p, we
documented the elongation capacities of preformed Ure2p 42–79,
1–79 and 1–93 fibrils in the presence of soluble full-length Ure2p.
We show that fibrils made of the N-terminal domain of Ure2p are
devoid of seeding capacities unlike those made of the full-length
protein. Our data suggest that the induction of [URE3] by fibrils
made of Ure2p N-terminal domain is the consequence of de novo
formation of prion particles following, for example, titration within
the cells of a specific set of molecular chaperones by the fibrils. The
inability of Ure2p 42–79, 1–79 and 1–93 fibrils to seed the
assembly of soluble full-length Ure2p further suggest that fibrils
made of authentic Ure2p share neither a scaffold nor structural
similarities with Ure2p 42–79, 1–79 and 1–93 amyloids.
Results
Structure and Assembly of Ure2p prion domain
fragments
We previously reported that the prion domain of Ure2p is
flexible [13,23]. GST-Ure2p 1–42, 42–79, 1–79, 1–93 (Ure2p1–
42, 43–79, 1–79 and 1–93 correspond to Ure2p N-terminal
fragments spanning amino acid residues 1 to 42, 43 to 79, 1 to 79
and 1–93, respectively) and glutathione S-transferase (GST) alone
exhibit similar far UV circular dichroism (CD) spectra (Figure 1B).
The CD difference spectra of GST-Ure2p 1–42, 42–79, 1–79, 1–
93 and GST shows that the absence of Ure2p N-terminal
fragments results in a decrease of the ellipticity signal between 200
and 190 nm, indicating that Ure2p 1–42, 42–79, 1–79, 1–93
remain in a random coil conformation within the fusion
polypeptides (Figure 1C). Pure, free Ure2p 1–42, 42–79, 1–79,
1–93 assemble spontaneously under physiological pH and ionic
strength into long unbranched fibrils (Figure 2A–D, respectively)
in a manner similar to full-length Ure2p (Figure 2E). Interestingly
however, while full-length Ure2p, Ure2p 42–79, 1–79 and 1–93
bind thioflavin T (ThT) and exhibit a typical sigmoid assembly
curve, Ure2p 1–42 does not bind ThT (Figure 2F). Comparison of
the assembly kinetics of free Ure2p 42–79, 1–79 and 1–93 and full-
length Ure2p show that the free N-terminal fragments of Ure2p
assemble much faster that the authentic protein (figure 2F), while
GST-Ure2p 42–79, 1–79 and 1–93 assemble slower than full-
length Ure2p (not shown). The electron micrographs of negatively
stained samples of free Ure2p 1–42, 42–79, 1–79, 1–93 and full-
length Ure2p incubated for 90 h at 6uC reveal that all
polypeptides, including Ure2p 1–42, assemble into fibrils that
are 5–10 nm in diameter while full-length Ure2p fibrils and fibrils
obtained upon incubation of GST-Ure2p 1–42, 42–79, 1–79 and
1–93 for 150 hours are thicker (25 nm wide, Figure S1).
Furthermore, while fibrillar full-length Ure2p, GST-Ure2p 1–42,
42–79, 1–79 and 1–93 have curly appearance, Ure2p 1–42, 42–
79, 1–79 and 1–93 are stiff. The finding that Ure2p 1–42
assembles into fibrils indistinguishable from fibrillar Ure2p 42–79,
1–79, 1–93 is surprising as assembly is not accompanied by ThT
binding.
Secondary structure content of fibrillar Ure2p 1–42, 42–
79, 1–79 and 1–93
Previous results have shown that full-length Ure2p fibrils
assembled under physiologically relevant conditions exhibit Four-
ier Transform Infrared Spectroscopy (FTIR) spectra typical of
proteins with high helical content [16–17]. Fibrillar Ure2p 42–79,
1–79 and 1–93 exhibit FTIR spectra in deuterium oxide (D2O)
typical of b-sheet rich amyloids and dominated by a strong
absorbance at 1625 cm
21 (Figure 3A). Fourier deconvolution of
fibrillar Ure2p 1–79, 42–79 and 1–93 indicates a b-sheet content
of over 38% (Figure S2 A–D, Table 1). The latter are organized
into a cross-b core as revealed by the fibre X-ray diffraction
pattern that shows a sharp equatorial reflexion at 4.7 A ˚ and a
fuzzy reflexion at 10 A ˚ suggesting partial disorder in the b-sheet
packing within the fibrils (Figure 3B).
Interestingly the FTIR spectra of polymerized Ure2p 1–42 lies
between the helical spectrum of full-length Ure2p and that of the
amyloid forming peptides Ure2p 42–79, 1–79 and 1–93 with an a-
helical content of 16% and a b-sheet content 15% (Figure S2 E,
Table 1). The amyloid nature of fibrillar Ure2p 1–42, 42–79, 1–79
and 1–93 was further confirmed by the finding that they resist SDS
treatment (figure 3C).
Secondary structure changes during the assembly of
Ure2p 1–79
The assembly of soluble Ure2p 1–79 into fibrils was followed by
measurement of the circular dichroism. A spectrum of typical
random coils is observed during the early stages of assembly i.e.
Figure 1. Characterization of recombinant Ure2p and its N-terminal fragments. A, Schematic representation of full-length Ure2p (the
flexible N-terminal domain is coloured black while the compactly folded C-terminal domain is coloured grey) and the different fragments of its N-
terminal domain expressed fused to GST. The numbers refer to amino acid residues. GST is shown as a circle. The TEV cleavage site engineered
between GST and the N-terminal fragments of Ure2p is indicated by an arrow-head. B, CD spectra of GST alone (6), GST-Ure2p 1–93 (e), GST-Ure2p
1–79 (n), GST-Ure2p 42–79 (%) and GST-Ure2p 1–42 (m). C, CD difference difference spectrum between GST and GST-Ure2p 1–93 (e), GST-Ure2p 1–
79 (n), GST-Ure2p 42–79 (%) and GST-Ure2p 1–42 (m).
doi:10.1371/journal.pone.0009760.g001
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treatment (Figure 4A, red hair-line), with a minimum of ellipticity
at 198 nm. Later measurements indicate a decrease in ellipticity at
198 nm and an increase in ellipticity at 220 nm (corresponding to
a b-sheet signal) over 150 minutes. An isobestic point is observed
at 207 nm, indicative of a system with two temperature-
independent components in equilibrium [24]. The time courses
of ellipticity variation at 198 and 220 nm (figure 4B) correlate with
ThT binding (figure 4C).
To assess the secondary structure changes that accompany
Ure2p 1–79 assembly into fibrils, the recorded spectra were
deconvoluted using the software CDSSTR [25] and soluble
protein reference dataset spectra. The secondary structure content
of soluble Ure2p 1–79 spectra at the early stages of assembly
consist of 19% b-sheet, 22% a-helix and 60% disordered while
that of fibrillar Ure2p 1–79 is 17% b-sheet, 53% a-helix, 30%
disordered. The high a-helical contribution comes presumably
from a helical fibrillar scaffold that impacts the CD spectrum, and
the use of inappropriate CD reference set of b-rich proteins
spectra for deconvolution [26]. To overcome this bias, we
compared soluble and fibrillar Ure2p 1–79 spectra to that of
soluble and fibrillar a-synuclein. The secondary structure content
of the amyloid form of a-synuclein was determined recently with
accuracy from solid-state NMR measurements [27] it consists of
27% of b-sheet and 73% other. Comparison of the molar
ellipticity signals recorded upon the assembly of Ure2p 1–79 and
full-length a-synuclein allowed us estimate the b-sheet content of
fibrillar Ure2p 1–79 to 39%, consistent with FTIR measurements.
The fibrillar forms of Ure2p and its N-terminal fragments
and their respective seeding capacities
The prion concept is based on the capacity of minute amounts of
aggregated prion molecules to convert the soluble form into high
molecular weight aggregates [28]. Fibrils made in vitro of Ure2p prion
domain induce [URE3] trait appearance when introduced in the
cytoplasm of S. cerevisiae [22]. This is either the consequence of full-
length Ure2p conversion into fibrilsvia a seeding process or the de novo
induction of [URE3]bydepletionofspecificmolecularchaperonesby
the fibrillar form of the prion domain of Ure2p and perturbed
molecular chaperone homeostasis.
To distinguish between the two possibilities, we assayed in vitro
the ability of the fibrillar form of Ure2p 1–79 to seed the assembly
of full-length Ure2p. The assembly kinetics, followed by ThT
binding, were compared to that where full-length Ure2p fibrils and
fibrils sharing no primary structure similarity with the prion
domain of Ure2p e.g. a-synuclein fibrils are used to seed the
assembly of soluble Ure2p. The initial elongation rates presented
in figure 5A show that fibrillar full-length Ure2p seed most
efficiently soluble full-length Ure2p assembly. Ure2p 1–93 fibrils in
a manner similar to a control reaction containing fibrillar a-
synuclein seeds do not induce the assembly of soluble Ure2p. We
conclude from this observation that the limited induction of Ure2p
assembly we observe upon addition to fibrillar Ure2p 1–93 or a-
synuclein is not due to a nucleating activity per se but rather due to
an unspecific process such as those observed upon addition of PEG
in protein solutions upon protein crystallization assays [29]. The
assembly of soluble Ure2p into protein fibrils was significantly
Figure 2. Ultra-structural and kinetic characterization of Ure2p 1–42, Ure2p 42–79, Ure2p 1–79, Ure2p 1–93 and full-length Ure2p
assemblies. Negatively stained electron micrographs of Ure2p 1–42, Ure2p 42–79, Ure2p 1–79, Ure2p 1–93 and full-length Ure2p assemblies
generated upon incubation of the different polypeptides (40 mM) for 80 h at 12uC in buffer A are shown in A–E, respectively. The scale bar in A–E
represents 100 nm. F, assembly kinetics at 12uC of full-length Ure2p (N), Ure2p 1–42 (m), Ure2p 42–79 (%), Ure2p 1–79 (n) and Ure2p 1–93 (e),
40 mM, at 12uC in buffer A followed by Thoflavin T binding. The error bars indicate the standard deviation in three independent measurements.
doi:10.1371/journal.pone.0009760.g002
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identical concentrations of fibrillar full-length Ure2p, upon
addition of higher Ure2p 1–93 and a-synuclein seed concentra-
tions (Figure S3). Nanoparticles and charged polysaccharides have
been proposed to adsorb proteins, thus either affecting their
conformational state or their local concentration, and as a
consequence their assembly properties [30–32]. Ure2p assembly
induction by elevated concentration of preformed Ure2p 1–93
fibrils which is of a similar extent to that of the unrelated a-
synuclein fibrils is consistent with this view and suggests it is not
due to the nucleation of Ure2p by preformed Ure2p1–93 fibrils.
To further determine whether the induction of full-length
Ure2p assembly observed upon dilution of preformed Ure2p 1–93
and a-synuclein fibrils is due to a seeding activity, we examined the
polymers in the electron microscope. Given that Ure2p 1–93
fibrils are 5 nm wide (Figure 5B) while full-length Ure2p fibrils are
25 nm wide (Figure 5C) one would expect to see if Ure2p 1–93
fibrils seed full-length Ure2p assembly thick fibrils with thin ends.
Similarly, thin fibrils with thick ends should be observed if fibrillar
full-length Ure2p was capable of seeding soluble Ure2p 1–93
assembly. None of the polymers we observed had such appearance
in the electron microscope. In contrast, thin and thick fibrils were
found to be lying next to each other (Figure 5, D and E). This
suggests that the full-length Ure2p assembly induction observed
upon addition of preformed Ure2p 1–93 and a-synuclein fibrils is
unspecific, due to a crowding effect. To further determine whether
Ure2p 1–93 co-assemble with full-length Ure2p, soluble Ure2p 1–
93 were mixed with soluble full-length Ure2p and the assembly
reaction was monitored by ThT binding. The assembly kinetics of
full-length Ure2p alone or in the presence of Ure2p 1–93 as well as
that of Ure2p 1–93 alone are presented in figure 5F. The data
show in an unquestionable manner that the assembly kinetics are
additive. Given that the assembly of Ure2p 1–93 is faster than that
of full-length Ure2p two phases accounting for the independent
assembly of each polypeptide are observed. This conclusion is
further confirmed upon observation in the electron microscope of
the fibrils generated in vitro. While thin fibrils made of Ure2p 1–93
are observed in the early stages of assembly, a mixed population of
thin and thick fibrils is observed during the late stages of assembly
(Figure S4). This further confirms that Ure2p 1–93 neither co-
assemble with nor seed full-length Ure2p.
Discussion
In the present study we show that the prion domain of Ure2p in
whole or in parts assemble into fibrils of amyloid nature. In
contrast, the full-length prion assembles into helical fibrils. Thus,
the intrinsic assembly propensity of Ure2p prion domain into
fibrils of amyloid nature appears to be abolished by its covalent
association with the functional domain of the protein that leads to
the generation of fibrils with high a-helical content. The
counteracting activity of Ure2p C-terminal domain strongly
suggests the existence of a crosstalk between the two protein
moieties. The latter could theoretically lead to the acquisition of a
defined structure by the N-terminal domain. Comparison of the
CD difference spectra of full-length Ure2p and Ure2pC-terminal
domain [23] and that of the GST-prion domain fusion and GST
reveal however that Ure2p prion domain is poorly structured
whether in its natural context or fused to the C-terminal end of
GST i.e. establishing interaction with the rest of the protein or not,
respectively.
The finding that Ure2p 42–79 has a higher propensity to
assemble into amyloid fibrils than Ure2p 1–42 suggests that the
latter polypeptide stretch modulates aggregation in its natural
context in a negative manner. This agrees with the finding that
amino-acid residues centred around residue 6 interact with those
centred around residue 137 in assembly competent Ure2p [19].
The vast majority of natively unfolded polypeptides have been
shown to form fibrils of amyloid nature. The finding that free
Figure 3. Structural characterization of fibrillar Ure2p 1–42, Ure2p 42–79, Ure2p 1–79, Ure2p 1–93 by FTIR spectroscopy, X-ray fiber
diffraction and filter trapping. A, FTIR spectra of fibrillar Ure2p 1–42 (m), Ure2p 42–79 (%), Ure2p 1–79 (n), Ure2p 1–93 (e) and full-length Ure2p
(N). B, X-ray diffraction pattern of fibrillar Ure2p1-93 (left side of the panel). The pattern shows a sharp refexion at 4.7 A ˚ (black arrow head) that
exhibits an increased intensity along the meridian and that characterizes amyloid fibrils. The X-Ray diffraction pattern was analysed using FibreFix
version 1.3.1 software. Circular average was achieved over 180 degrees, the angular average is shown as a function of the radius in the right side of
the panel. C, the resistance of fibrillar Ure2p 1–42, 1–79 and 1–93 to SDS (2%) was assayed by filtration through cellulose acetate membranes
(0.20 mm pore size, Millipore Corp., Bedford, MA, USA). The filter was stained with amido black.
doi:10.1371/journal.pone.0009760.g003
Table 1. Secondary structure content of fibrillar full-length
Ure2p, Ure2p 1–94, 1–79, 1–42 and 42–79 estimated from the
deconvolution of the FTIR spectroscopic measurements
presented in Figure S2.
a-helix [%] b-sheet [%] Other [%]
Ure2p 1–94 16 37 47
Ure2p 1–79 21 38 41
Ure2p 1–42 16 15 69
Ure2p 42–79 21 25 54
U r e 2 p W T 3 51 64 9
doi:10.1371/journal.pone.0009760.t001
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suggests this peptide is natively unfolded. In contrast, the complex
FTIR spectra recorded for free Ure2p 1–42 assemblies suggest
that the peptide retain elements of secondary structure. Taken
together our observations suggest that the N-terminal half of
Ure2p prion domain not only interact with the C-terminal moiety
of the prion protein but also possess elements of secondary
structure.
Figure 4. Secondary structure changes accompanying the assembly of Ure2p 1–79. A, Time course of Ure2p 1–79 (10 mM) assembly at
15uC followed by CD. The spectra recorded at time 0, 10, 20, 30, 40 and 60 min, purple – red, respectively, are shown. The CD spectra of soluble (red
dashed line) and fibrillar (blue dashed line) a-synuclein (720 mM) are also shown. An isodichroic point is observed at 208 nm for Ure2p, 207 nm for a-
synuclein. B, b-sheets formation upon the assembly of Ure2p 1–79 was derived from comparison of the changes in the CD spectra of Ure2p 1–79 and
a-synuclein (which structure in amyloid fibrils is known) during assembly at 220 (#) and 200 (N) nm for b-sheets and random coil structures,
respectively. The same assembly kinetic monitored by ThT binding is shown in C.
doi:10.1371/journal.pone.0009760.g004
Figure 5. Cross-seeding capacities of fibrillar full-length Ure2p and Ure2p 1–93. A, Elongation of preformed full-length Ure2p fibrils,
2.5 mM(N) and Ure2p 1–93, 2.5 mM( e) in the presence of soluble full-length Ure2p, 50 mM monitored by ThT binding. The elongation reactions were
performed at 15uC. The assembly of soluble full-length Ure2p in the absence of added seeds (#) and the presence of preformed a-synuclein fibrils,
2.5 mM( 6) are shown as controls. Electron micrographs of assembly reaction products of B, Ure2p 1–93 alone, C, full-length Ure2p alone, D, full-
length Ure2p in the presence of preformed fibrillar Ure2p 1–93 and E, Ure2p 1–93 in the presence of preformed fibrillar full-length Ure2p. F, assembly
of soluble full-length Ure2p, 50 mM(N), Ure2p 1–93, 50 mM( e) and full-length Ure2p and Ure2p 1–93, 50 mM each (n) monitored by ThT binding. The
dashed line corresponds to the sum of the ThioT fluorescence recorded upon assembly of Ure2p 1–93 and soluble full-length Ure2p. The error bars in
A and F indicate the standard deviation in three independent measurements.
doi:10.1371/journal.pone.0009760.g005
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propensity than free Ure2p 1-42. It is possible that the ensemble of
conformational states adopted by free Ure2p 1–42 is wider than
that the polypeptide can explore when it is physically attached to
the C-terminal end of GST. Thus, one reasonable explanation for
this observation is that Ure2p 1–42 in GST-Ure2p 1–42 populates
an assembly competent state faster than free Ure2p 1–42 because
of its limited freedom and assemble more readily, as measured
using thioflavin T binding.
Prions propagate by incorporation of soluble prion proteins into
high molecular weight, fibrillar, oligomers. As the formation of
stable nuclei following the conformational change that yield
assembly competent prions is rate limiting, preformed prion
aggregates seed very efficiently the assembly of soluble prions into
fibrillar structures. The fibrillar form of full-length Ure2p
generated under physiological experimental conditions seeds very
efficiently the assembly of intact Ure2p. In contrast, fibrils made of
the prion domain of the protein lack the ability to incorporate full-
length Ure2p. This indicates that Ure2p N-terminal domain
within its natural context does not populate a conformational state
that incorporate within the amyloids that are generated when the
prion domain is free in solution and out of its physiological
context. This further support the model we proposed several years
ago where the assembly of the prion Ure2p is driven by the
establishment of intermolecular interactions between the N- and
C-terminal domains of two consecutive Ure2p dimers and where
the functional C-terminal domain of the protein is tightly involved
in the fibrillar scaffold. Indeed, if the alternative model where
assembly is driven by the stacking of Ure2p N-termini into a
systematically H-bonded b-sheet core running along the fibrils to
which the C-terminal domain is attached through a flexible region
[33] was correct, amyloids made of free Ure2p N-terminal domain
would seed the assembly of full-length Ure2p.
Fibrils made in vitro of Ure2p N-terminal domain were shown
recently to induce, although to a lesser extent than those made of
full-length Ure2p, [URE3] occurrence when reintroduced in yeast
cells [22]. The results we report in this study suggest that [URE3]
occurrence might be the consequence of the conversion of soluble
cytosolic Ure2p into an insoluble form upon introduction of fibrils
made of full-length Ure2p as fibrillar Ure2p seeds very efficiently
the assembly of full-length Ure2p. Given that the amyloid fibrils
made of the N-terminal domain of the protein i-exhibit no full-
length Ure2p seeding capacity, ii- most likely expose to the solvent
surface areas that differ from those exposed by full-length Ure2p
fibrils, the process by which they induce [URE3] must differ from
that of full-length Ure2p fibrils. The occurrence of [URE3] has
been reported to be highly dependent on the expression levels of a
number of molecular chaperones [34–37]. In addition, we have
shown that the assembly of Ure2p is finely tuned by molecular
chaperones in vitro [38]. Thus, it is possible that the induction of
the prion trait upon reintroduction of fibrils made of Ure2p N-
terminal domain is the consequence of their interaction interaction
with molecular chaperones leading to de novo occurrence of
[URE3]. The latter considerations and the finding that the [URE3]
induction efficiency by full-length Ure2p fibrils is higher than that
of fibrils made of the N-terminal domain of the protein [22] might
thus reflect two independent pathways leading to a similar end
point observable.
Further characterization of the affinity of molecular chaperone
for fibrillar full-length Ure2p and Ure2p N-terminal domain using
binding measurements and proteomic analysis should allow
establishing whether the differences in the efficiency of [URE3]
induction recorded for the two kinds of fibrils is due to two
independent pathways leading to prion trait occurrence. This will
undoubtedly contribute to a better understanding of the molecular
events leading to [URE3] occurrence and propagation.
Materials and Methods
Construction of expression vectors and expression of
Ure2p and related fusion proteins
Full length, wild type Ure2p (Ure2p) was expressed in E.coli
BL21 DE3 codon plus strain (Stratagene
TM) and purified as
described previously [13]. The N-terminal fragments of the prion
domain spanning residues 1–42, 43–79, 1–79 and 1–93 were
produced fused to the C-terminal end of GST with a TEV
protease [39] cleavage site engineered between the GST and the
N-terminal fragments of Ure2p (Figure 1A). PCR amplified
fragments using specific primer (table S1) were subcloned into
pETM-30 vector (EMBL, Heidelberg). The PCR products were
digested by NdeI and NcoI, and ligated in pETM30 vector
digested with the same enzymes. All construct were sequenced.
The fusion geometry allows the production of soluble undegraded
N-terminal fragments of the Ure2p prion domain.
Ure2p and the different fusion proteins were expressed in E.coli
stain BL21 DE3 codon plus by addition of 0.5 mM isopropyl b-D-
1-thiogalactopyranoside (IPTG). The bacterial pellets were
resuspended in lysis buffer (Tris pH 7.5 10 mM, EDTA 1 mM,
0.1 mM phenylmethylsulfonyl fluoride (PMSF)). The cells were
disrupted by sonication at 4uC. The lysate was clarified by
centrifugation (25 minutes at 4uC, 20000 g) and loaded on the
appropriate column for protein purification.
Protein purification
Full-length Ure2p and a-synuclein were purified as previously
described [13,23,40]. The GST-N-terminal fragments of Ure2p
prion domain were purified using a 10 ml Glutathione sepharose 4
fast flow column (GE healthcare). The column was washed with
100 ml of buffer A (Tris pH 7.5 10 mM, KCL 200 mM, 1 mM
beta-mercaptoethanol (bME)) after the samples were loaded and
was eluted with 10 ml of buffer A supplemented with 10 mM
Glutathione. Fraction containing the fusion proteins were
immediately aliquoted, flash-frozen in liquid nitrogen, and stored
at 280uC.
To generate free Ure2p 1–42, 42–79, 1–79 and 1–93, the fusion
proteins were immobilized on a 10 ml Glutathione sepharose
column. The column was filled with 6xHis-tagged TEV protease
(0.3 mg/ml in Buffer A). The column was then washed with buffer
A and the TEV protease was remove inline by a 5 ml His-trap
chelating column (GE healthcare). Fraction containing pure free
Ure2p 1–42, 42–79, 1–79 and 1–93 were immediately aliquoted,
flash-frozen in liquid nitrogen, and stored at 280uC.
All purified Ure2p N-terminal fragments and fusion proteins
were checked by MALDI-TOF mass spectrometry. Purified Ure2p
1–42, 42–79, 1–79 and 1–93 analysed on Tris-Tricine SDS PAGE
exhibit an abnormal migration with higher apparent molecular
weights and stain pink upon staining with Coomassie blue R250
(not shown).
Assembly of full-length Ure2p and Ure2p 1–42, 42–79,
1–79 and 1–93 into protein fibrils, seeding and cross-
seeding experiments
The assembly of full-length Ure2p, Ure2p 1–42, 42–79, 1–79
and 1–93 was achieved by incubation of the proteins at 6uC
without shaking in buffer A. The assembly reaction was monitored
using ThT binding [41] using a Cary Eclipse fluorescence
spectrophotometer (Varian Inc., Palo Alto, CA). The elongation
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the presence of soluble full-length Ure2p and of Ure2p fibrils in
the presence of soluble Ure2p 1–42, 42–79, 1–79 and 1–93 were
measured upon diluting the preformed fibrils in the presence of the
soluble proteins at a molar ratio 5:100. Fibrillar a-synuclein was
added to control reaction to assess the unspecific effect of fibrils
addition on Ure2p and its N-terminal fragments assembly
reactions.
Assemblies were examined following negative staining with 1%
Uranyl acetate on carbon-coated grids (200 mesh) in a Jeol 1400
transmission electron microscope. Images were recorded with a
Gatan Orius CCD camera (Gatan, Pleasanton, CA).
X-ray fiber diffraction measurements
The fibrillar samples were spun 13 000 rpm for 15 min at 4uC.
The pellets were resuspended twice in distilled water. Pelleted
fibrils were introduced into a 1 mm diameter glass capillary and
dehydrated at room temperature for two days. X-ray fiber
diffraction patterns were collected on a MAR345 image plate
(MArresearch Gmbh, Germany) using a Rigaku RU200 rotating-
anode generator source (beam size 1006100 mm). The acquisition
parameters were set to 300 mm sample-to-detector distance, and
20-minute exposure. Images were processed by Mosflm [42] and
FibreFix version 1.3.1 software (http:/www.fibre-diffraction.ac.uk).
Fourier transform infrared spectrometry
Fibrillar samples (2 mg) were spun at 16000 g at 4uC for 10 min
and resuspended in 100 mlD 2O. Following a second centrifuga-
tion/resuspension step, infrared spectra were recorded on a
JASCO 660 Plus FTIR spectrometer equipped with a Mercury
Cadmium Telluride (MCT) detector using the attenuated total
reflectance mode. The background consisted of D2O. A total of
256 interferograms were collected with a resolution of 1 cm
21.
Circular dichroism
The CD of GST-Ure2p 1–42, GST-Ure2p 1–79 and GST-
Ure2p 1–93 were recorded at 20uC using a JASCO J810
dichrograph using 1 mm pathlength quartz cuvettes (Hellma)
containing 150 ml of the protein solutions. Synchrotron Radiation
Circular Dichroism (SRCD) of free Ure2p 1–79 was recorded at
15uC on UV I beamline at ISA (Aarhus university synchrotron
radiation facility, Aarhus, DK). Samples were loaded into a
500 mm pathlength suprasil round cell (HELLMA). Acquisitions at
1 nm steps, between 280 to 175 nm were performed in triplets.
Averaged sample spectra subtracted from their corresponding
buffer Baseline. Spectral magnitude was veryfied using a solution
of (+)-camphour-10-sulphonic acid (CSA).
All spectra were normalized to the mean residue weight
ellipticity (hMRW) [deg cm2/dmole] using the equation
h(l)MRW = h(l)mdeg/10?c?n?d where h(l)mdeg is the recorded
spectra in millidegrees, n is the number of amino acid residues, c is
the sample concentration in moles per liter and d is the path length
of the cuvette in centimeters.
Accurate protein concentration measurements were done by
quantitative amino acid analysis (QAA) performed at the Institut
Pasteur (Unit Chemistry of Biomolecules).
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